Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 111

Similar articles for PubMed (Select 24223903)

1.

Neuroprotection in a novel mouse model of multiple sclerosis.

Lidster K, Jackson SJ, Ahmed Z, Munro P, Coffey P, Giovannoni G, Baker MD, Baker D.

PLoS One. 2013 Nov 4;8(11):e79188. doi: 10.1371/journal.pone.0079188. eCollection 2013.

2.

Limiting multiple sclerosis related axonopathy by blocking Nogo receptor and CRMP-2 phosphorylation.

Petratos S, Ozturk E, Azari MF, Kenny R, Lee JY, Magee KA, Harvey AR, McDonald C, Taghian K, Moussa L, Mun Aui P, Siatskas C, Litwak S, Fehlings MG, Strittmatter SM, Bernard CC.

Brain. 2012 Jun;135(Pt 6):1794-818. doi: 10.1093/brain/aws100. Epub 2012 Apr 28.

3.

Lesional-targeting of neuroprotection to the inflammatory penumbra in experimental multiple sclerosis.

Al-Izki S, Pryce G, Hankey DJ, Lidster K, von Kutzleben SM, Browne L, Clutterbuck L, Posada C, Edith Chan AW, Amor S, Perkins V, Gerritsen WH, Ummenthum K, Peferoen-Baert R, van der Valk P, Montoya A, Joel SP, Garthwaite J, Giovannoni G, Selwood DL, Baker D.

Brain. 2014 Jan;137(Pt 1):92-108. doi: 10.1093/brain/awt324. Epub 2013 Nov 27.

4.

Retinal ganglion cell damage induced by spontaneous autoimmune optic neuritis in MOG-specific TCR transgenic mice.

Guan Y, Shindler KS, Tabuena P, Rostami AM.

J Neuroimmunol. 2006 Sep;178(1-2):40-8. Epub 2006 Jul 7.

PMID:
16828169
5.

Neuroprotective effects of recombinant T-cell receptor ligand in autoimmune optic neuritis in HLA-DR2 mice.

Adamus G, Brown L, Andrew S, Meza-Romero R, Burrows GG, Vandenbark AA.

Invest Ophthalmol Vis Sci. 2012 Jan 25;53(1):406-12. doi: 10.1167/iovs.11-8419.

6.

Calcium influx and calpain activation mediate preclinical retinal neurodegeneration in autoimmune optic neuritis.

Hoffmann DB, Williams SK, Bojcevski J, Müller A, Stadelmann C, Naidoo V, Bahr BA, Diem R, Fairless R.

J Neuropathol Exp Neurol. 2013 Aug;72(8):745-57. doi: 10.1097/NEN.0b013e31829c7370.

PMID:
23860028
7.

[Optic neuritis--immunological approach to elucidate pathogenesis and develop innovative therapy].

Kezuka T.

Nihon Ganka Gakkai Zasshi. 2013 Mar;117(3):270-91; discussion 292. Review. Japanese.

PMID:
23631257
8.

Optical coherence tomography segmentation reveals ganglion cell layer pathology after optic neuritis.

Syc SB, Saidha S, Newsome SD, Ratchford JN, Levy M, Ford E, Crainiceanu CM, Durbin MK, Oakley JD, Meyer SA, Frohman EM, Calabresi PA.

Brain. 2012 Feb;135(Pt 2):521-33. doi: 10.1093/brain/awr264. Epub 2011 Oct 17.

9.

Transgenic inhibition of astroglial NF-κB protects from optic nerve damage and retinal ganglion cell loss in experimental optic neuritis.

Brambilla R, Dvoriantchikova G, Barakat D, Ivanov D, Bethea JR, Shestopalov VI.

J Neuroinflammation. 2012 Sep 10;9:213. doi: 10.1186/1742-2094-9-213.

10.

Multiple neuroprotective mechanisms of minocycline in autoimmune CNS inflammation.

Maier K, Merkler D, Gerber J, Taheri N, Kuhnert AV, Williams SK, Neusch C, Bähr M, Diem R.

Neurobiol Dis. 2007 Mar;25(3):514-25. Epub 2007 Jan 18.

PMID:
17239606
11.

Myelin oligodendrocyte glycoprotein-specific T cell receptor transgenic mice develop spontaneous autoimmune optic neuritis.

Bettelli E, Pagany M, Weiner HL, Linington C, Sobel RA, Kuchroo VK.

J Exp Med. 2003 May 5;197(9):1073-81.

12.

HIV-Tat-mediated Bcl-XL delivery protects retinal ganglion cells during experimental autoimmune optic neuritis.

Diem R, Taheri N, Dietz GP, Kuhnert A, Maier K, Sättler MB, Gadjanski I, Merkler D, Bähr M.

Neurobiol Dis. 2005 Nov;20(2):218-26.

PMID:
16242630
13.

Effects of glatiramer acetate and interferon-beta on neurodegeneration in a model of multiple sclerosis: a comparative study.

Maier K, Kuhnert AV, Taheri N, Sättler MB, Storch MK, Williams SK, Bähr M, Diem R.

Am J Pathol. 2006 Oct;169(4):1353-64.

14.

HE3286 reduces axonal loss and preserves retinal ganglion cell function in experimental optic neuritis.

Khan RS, Dine K, Luna E, Ahlem C, Shindler KS.

Invest Ophthalmol Vis Sci. 2014 Aug 19;55(9):5744-51. doi: 10.1167/iovs.14-14672.

15.

Ciliary neurotrophic factor protects retinal ganglion cells from secondary cell death during acute autoimmune optic neuritis in rats.

Maier K, Rau CR, Storch MK, Sättler MB, Demmer I, Weissert R, Taheri N, Kuhnert AV, Bähr M, Diem R.

Brain Pathol. 2004 Oct;14(4):378-87.

PMID:
15605985
16.

Long-term suppression of neurodegeneration in chronic experimental optic neuritis: antioxidant gene therapy.

Qi X, Sun L, Lewin AS, Hauswirth WW, Guy J.

Invest Ophthalmol Vis Sci. 2007 Dec;48(12):5360-70.

PMID:
18055782
17.

A serial study of retinal changes following optic neuritis with sample size estimates for acute neuroprotection trials.

Henderson AP, Altmann DR, Trip AS, Kallis C, Jones SJ, Schlottmann PG, Garway-Heath DF, Plant GT, Miller DH.

Brain. 2010 Sep;133(9):2592-602. doi: 10.1093/brain/awq146. Epub 2010 Jun 20.

18.

Calpain inhibitor attenuated optic nerve damage in acute optic neuritis in rats.

Das A, Guyton MK, Smith A, Wallace G 4th, McDowell ML, Matzelle DD, Ray SK, Banik NL.

J Neurochem. 2013 Jan;124(1):133-46. doi: 10.1111/jnc.12064. Epub 2012 Nov 22.

19.

Combined therapy with methylprednisolone and erythropoietin in a model of multiple sclerosis.

Diem R, Sättler MB, Merkler D, Demmer I, Maier K, Stadelmann C, Ehrenreich H, Bähr M.

Brain. 2005 Feb;128(Pt 2):375-85. Epub 2004 Dec 15.

20.

Optic neuritis.

Toosy AT, Mason DF, Miller DH.

Lancet Neurol. 2014 Jan;13(1):83-99. doi: 10.1016/S1474-4422(13)70259-X. Review.

PMID:
24331795
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk